Skip to main content

Welcome to a Grasp lesson

Create a free account to keep studying and create your own study path.

Lesson 6

How Supportive Care Improves Survival by Treating Fluid Loss

Recommended resources

Hello. In the previous lesson, you saw why a person with compatible symptoms and a plausible exposure needs assessment even if an early RT-PCR test is negative. Care does not have to wait for a final diagnosis: clinicians can address dangerous symptoms while maintaining precautions for a suspected case.

This lesson follows one particularly important threat to survival. Ebola disease can cause substantial vomiting and diarrhoea. When the body loses more fluid than it takes in, blood circulation, kidney function, and the balance of salts in the blood can all deteriorate. You will see how supportive care responds to those connected problems—and why it remains important even when a virus-specific treatment is available.


Fluid loss is a threat to circulation

Picture a patient who has had frequent watery stools, is vomiting, and can drink only a little. The most visible problem is the fluid leaving the body. The less visible problem is that too little fluid may remain in the circulation to deliver enough blood to the organs. Clinicians call this hypovolaemia, or low circulating fluid volume.

As the shortage worsens, blood pressure can fall and organs receive inadequate blood flow. This is one route to shock. The kidneys are especially vulnerable because they depend on adequate blood flow to filter the blood and produce urine. Severe illness may also affect organs through mechanisms other than dehydration, so replacing fluid is crucial but does not explain or solve every complication of Ebola disease.

Read the opening care categories in this short account from Doctors Without Borders. Notice the distinction between reducing symptoms that cause fluid loss and replacing fluid that has already been lost.

Q&A: How Does MSF Care for Patients Suffering from Ebola? | Doctors Without Borders - USA

Doctors Without Borders describes how symptom control and hydration work together in patient care.

In the opening list of care categories, read the “Symptomatic care” and “Supportive care” entries, stopping before “Presumptive care.” Read these two entries, focusing on how the patient's ability to drink affects the choice of fluids.

Medication that eases vomiting may help someone keep down fluids. But symptom relief alone may not replace what has already been lost. That is why the amount a patient can actually take in, compared with continuing losses, matters more than simply offering a drink.



Replacing fluid: drinking when possible, IV fluids when necessary

Oral rehydration solution contains water and a measured balance of salts. For someone able to drink and retain enough of it, oral rehydration can replace ongoing losses and help prevent hypovolaemia. It may take active help from healthcare workers: a weak patient may not be able to prepare or drink enough without assistance.

If vomiting prevents drinking, or diarrhoea is causing losses faster than the patient can replace them by mouth, clinicians can give fluid intravenously (IV). The route changes, but the immediate purpose is the same: restore sufficient circulating volume to support blood pressure and blood flow to organs. It is not a choice based solely on whether a patient has Ebola; it is a choice guided by what the patient is losing and what they can take in.

Two bags of compound sodium lactate fluid hang from a pole. IV fluids can replace losses when drinking cannot keep pace, with the amount and composition guided by clinical assessment.

The following guideline provides the reasoning behind both routes. Its introduction also describes improvements in outcomes as supportive care developed during an outbreak. Treat those historical changes as evidence that better overall care matters, not as a precise measure of what IV fluids alone achieved: many aspects of care changed together.

Evidence-based guidelines for supportive care of patients with Ebola virus disease

This evidence-based guideline explains why clinicians prioritise rehydration and when IV fluids are recommended instead of oral intake alone.

In “Introduction,” read the illness and care overview. Then go to “Recommendations,” subsection “(1) Oral rehydration”: read its opening recommendation and the “Conclusion and remarks” passage beginning oral rehydration therapy. In subsection “(2) Parenteral administration of fluids,” read the IV recommendation, then find its “Conclusion and remarks” and read the clinical rationale. You can skim the intervening comparisons of outbreak mortality; focus on the conditions under which each route can keep pace with losses.

The practical distinction is adequate replacement, not “oral good, IV better.” Someone drinking enough may not need IV rehydration. Someone who cannot drink enough may need it urgently. For either patient, clinicians must keep reassessing because fluid losses and the patient's condition can change.



Replacing fluid is not enough by itself

Vomiting and diarrhoea can also disturb electrolytes—salts such as sodium and potassium that help nerves, muscles, and the heart function. Severe fluid loss can contribute to disturbances in the body's acid–base balance. If kidney function worsens, the body may become less able to regulate fluid and electrolytes. Thus, giving water without checking its effects may leave a dangerous imbalance uncorrected; giving too much fluid or the wrong electrolyte replacement can also cause harm.

Clinicians therefore track the patient's condition over time. Heart rate and blood pressure help show how circulation is coping. Stool losses and urine output provide clues about fluid leaving the body and how the kidneys are functioning. Blood tests, when available, reveal electrolyte and other biochemical abnormalities that cannot be judged reliably by appearance alone. Those findings help clinicians adjust fluids and correct abnormalities rather than assuming that one fixed amount will suit every patient.

Read the guideline's recommendations on monitoring. The detailed study statistics are less important here than the relationship between observing, treating, and reassessing.

Evidence-based guidelines for supportive care of patients with Ebola virus disease

Return to the supportive-care guideline to see why rehydration is paired with repeated clinical observations and blood chemistry tests.

Under “Recommendations,” find “(3) Systematic monitoring and charting of vital signs and volume status.” In its “Conclusion and remarks,” read the monitoring guidance. Then go to “(4) Serum biochemistry” and its “Conclusion and remarks”; read the guidance on blood chemistry. Focus on what each kind of measurement helps clinicians detect, rather than memorising numerical thresholds.

This attention requires trained staff and infection-prevention precautions. Placing an IV line and taking blood samples involve contact with potentially infectious material; healthcare workers must use appropriate protective practices. Safe, sustained observation is part of the treatment, not an optional extra after fluids have been given.

This brief video excerpt illustrates the same combination of fluid replacement, electrolyte correction, blood-pressure support, and symptom control. It discusses Bundibugyo virus disease; use it for the supportive-care principles, not as an up-to-date source on which virus-specific medicines are licensed.

Ebola Virus BDBV Fundamentals and Best Hope for Treatment

Watch the supportive-care portion of “Ebola Virus BDBV Fundamentals and Best Hope for Treatment” from MedCram for a concise clinical picture of what staff must manage at once.

Watch the care measures for the links between fluid, electrolytes, blood pressure, and symptoms. Continue through the staffing challenge to see why delivering and monitoring this care can become difficult when many patients need it simultaneously.



What supportive care changes—and what it does not

Return to the patient with frequent stools and vomiting. If they can take enough oral rehydration solution, that may help preserve circulation. If they cannot, IV fluid can replace losses that drinking cannot match. Repeated observations and blood tests then help the team detect worsening shock, kidney problems, or electrolyte disturbances and adjust treatment. This gives the body a better chance to survive the illness.

Supportive care does not directly eliminate the virus. It treats the consequences of illness that can themselves become life-threatening. It also does not guarantee recovery: Ebola disease can be severe for several reasons, and patients may need other forms of clinical support. Importantly, supportive care is relevant across Ebola disease caused by different viruses. Whether an additional virus-specific medicine is available is a separate question.



Key takeaways

Vomiting and diarrhoea can deplete circulating fluid, reduce blood flow to organs, and contribute to shock and kidney dysfunction. Oral rehydration helps when a patient can take in enough; IV fluids are important when oral intake cannot keep up with losses. Monitoring vital signs, urine and stool output, and blood chemistry helps clinicians correct fluid and electrolyte problems while avoiding inappropriate replacement.

Next, you will distinguish this broadly useful supportive care from monoclonal-antibody treatments whose licensed use depends on which Ebola virus is causing the illness.